AORT
ARTIVION, INC.
-0.90 (-3.60%)24.12USD92.0K成交股數1.2B市值–本益比(近四季)2.5股價營收比+11.3%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 7 · 2.6M · 4 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 3.5M |
| 近 180 天 淨額 | −3.5M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | 09-11 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出 | 11.5K | 24.97 | 287K | 40.2K | SEC |
| 2026-09-03 | 09-04 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出 | 1.5K | 26.02 | 39K | 51.6K | SEC |
| 2026-09-02 | 09-04 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出 | 6.5K | 27.27 | 177K | 53.1K | SEC |
| 2026-08-19 | 08-20 | Mackin James P | President & CEO | S 公開市場賣出 | 70.0K | 28.96 | 2.0M | 877K | SEC |
| 2026-08-14 | 08-17 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出 | 616 | 28.55 | 18K | 59.6K | SEC |
| 2026-08-14 | 08-17 | Berry Lance A | EVP, COO, CFO & Treasurer | S 公開市場賣出 | 715 | 28.55 | 20K | 210K | SEC |
| 2026-08-12 | 08-12 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 977 | 28.49 | 28K | 184K | SEC |
| 2026-06-11 | 06-15 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出(10b5-1) | 14.0K | 20.71 | 290K | 60.3K | SEC |
| 2026-06-11 | 06-15 | GREEN ANDREW M | SVP, Regulatory and Quality | M 選擇權執行 | 14.0K | 18.44 | 258K | 74.3K | SEC |
| 2026-06-11 | 06-15 | GREEN ANDREW M | SVP, Regulatory and Quality | S 公開市場賣出(10b5-1) | 30.0K | 20.69 | 621K | 60.3K | SEC |
| 2026-06-11 | 06-15 | GREEN ANDREW M | SVP, Regulatory and Quality | M 選擇權執行 | 30.0K | 11.03 | 331K | 90.3K | SEC |
| 2026-06-02 | 06-04 | SEMEDO ANTHONY B. | Director | J 其他 | 6.3K | – | – | 6.3K | SEC |
| 2026-06-02 | 06-04 | SEMEDO ANTHONY B. | Director | J 其他 | 6.3K | – | – | 40.6K | SEC |
| 2026-05-18 | 05-20 | Burbank Jeffrey H | Director | A 獲配股票 | 7.6K | – | – | 61.4K | SEC |
| 2026-05-18 | 05-20 | BEVEVINO DANIEL J | Director | A 獲配股票 | 7.6K | – | – | 158K | SEC |
| 2026-05-18 | 05-20 | Bullock James | Director | A 獲配股票 | 7.6K | – | – | 76.2K | SEC |
| 2026-05-18 | 05-20 | Borgstrom Marna P | Director | A 獲配股票 | 7.6K | – | – | 56.7K | SEC |
| 2026-05-18 | 05-20 | ACKERMAN THOMAS F | Director | A 獲配股票 | 7.6K | – | – | 157K | SEC |
| 2026-05-18 | 05-20 | Salveson Jon W | Director | A 獲配股票 | 7.6K | – | – | 137K | SEC |
| 2026-05-18 | 05-20 | Hoff Elizabeth A | Director | A 獲配股票 | 7.6K | – | – | 34.8K | SEC |
| 2026-05-18 | 05-20 | SEMEDO ANTHONY B. | Director | A 獲配股票 | 7.6K | – | – | 47.0K | SEC |
| 2026-05-14 | 05-19 | Borgstrom Marna P | Director | A 獲配股票 | 7.8K | – | – | 56.9K | SEC |
| 2026-03-04 | 03-04 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 9.0K | 38.00 | 341K | 185K | SEC |
| 2026-03-03 | 03-04 | Davis John E | Chief Commercial Officer | S 公開市場賣出 | 4.6K | 37.78 | 173K | 231K | SEC |
| 2026-03-03 | 03-04 | Mackin James P | President & CEO | S 公開市場賣出 | 17.9K | 37.78 | 676K | 947K | SEC |
| 2026-03-03 | 03-04 | Berry Lance A | EVP, COO, CFO & Treasurer | S 公開市場賣出 | 6.3K | 37.78 | 239K | 211K | SEC |
| 2026-03-03 | 03-04 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 3.8K | 37.78 | 145K | 194K | SEC |
| 2026-03-03 | 03-04 | Horton Amy | VP, Chief Accounting Officer | S 公開市場賣出 | 901 | 37.78 | 34K | 139K | SEC |
| 2026-03-03 | 03-04 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 2.1K | 37.78 | 81K | 60.1K | SEC |
| 2026-03-02 | 03-04 | Holloway Jean F | SVP, General Counsel | A 獲配股票 | 27.8K | – | – | 198K | SEC |
| 2026-03-02 | 03-04 | Stanton Marshall S. | SVP, Clinical & MD Affair | A 獲配股票 | 21.8K | – | – | 62.2K | SEC |
| 2026-03-02 | 03-04 | Berry Lance A | EVP, COO, CFO & Treasurer | A 獲配股票 | 40.9K | – | – | 217K | SEC |
| 2026-03-02 | 03-04 | Davis John E | Chief Commercial Officer | A 獲配股票 | 28.8K | – | – | 235K | SEC |
| 2026-03-02 | 03-04 | Horton Amy | VP, Chief Accounting Officer | A 獲配股票 | 7.5K | – | – | 140K | SEC |
| 2026-03-02 | 03-04 | Mackin James P | President & CEO | A 獲配股票 | 117K | – | – | 965K | SEC |
| 2026-03-02 | 03-03 | Davis John E | Chief Commercial Officer | S 公開市場賣出 | 2.8K | 38.02 | 106K | 207K | SEC |
| 2026-03-02 | 03-03 | Horton Amy | VP, Chief Accounting Officer | S 公開市場賣出 | 641 | 38.02 | 24K | 133K | SEC |
| 2026-03-02 | 03-03 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 1.5K | 38.02 | 58K | 40.4K | SEC |
| 2026-03-02 | 03-03 | Berry Lance A | EVP, COO, CFO & Treasurer | S 公開市場賣出 | 5.2K | 38.02 | 197K | 176K | SEC |
| 2026-03-02 | 03-03 | Mackin James P | President & CEO | S 公開市場賣出 | 14.9K | 38.02 | 567K | 848K | SEC |
| 2026-03-02 | 03-03 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 2.2K | 38.02 | 83K | 170K | SEC |
| 2026-02-24 | 02-25 | Horton Amy | VP, Chief Accounting Officer | A 獲配股票 | 5.7K | – | – | 133K | SEC |
| 2026-02-24 | 02-25 | Horton Amy | VP, Chief Accounting Officer | S 公開市場賣出 | 830 | 35.69 | 30K | 127K | SEC |
| 2026-02-24 | 02-25 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 1.3K | 35.69 | 45K | 41.9K | SEC |
| 2026-02-24 | 02-25 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 1.7K | 35.69 | 60K | 152K | SEC |
| 2026-02-24 | 02-25 | Holloway Jean F | SVP, General Counsel | A 獲配股票 | 20.1K | – | – | 172K | SEC |
| 2026-02-24 | 02-25 | Mackin James P | President & CEO | A 獲配股票 | 97.0K | – | – | 863K | SEC |
| 2026-02-24 | 02-25 | Mackin James P | President & CEO | S 公開市場賣出 | 13.9K | 35.69 | 497K | 766K | SEC |
| 2026-02-24 | 02-25 | Berry Lance A | EVP, COO, CFO & Treasurer | A 獲配股票 | 37.5K | – | – | 181K | SEC |
| 2026-02-24 | 02-25 | Berry Lance A | EVP, COO, CFO & Treasurer | S 公開市場賣出 | 4.5K | 35.69 | 160K | 144K | SEC |
| 2026-02-24 | 02-25 | Davis John E | Chief Commercial Officer | A 獲配股票 | 20.4K | – | – | 209K | SEC |
| 2026-02-24 | 02-25 | Davis John E | Chief Commercial Officer | S 公開市場賣出 | 2.1K | 35.69 | 74K | 189K | SEC |
| 2026-02-23 | 02-25 | Davis John E | Chief Commercial Officer | S 公開市場賣出 | 3.8K | 37.59 | 142K | 191K | SEC |
| 2026-02-23 | 02-25 | Mackin James P | President & CEO | S 公開市場賣出 | 21.0K | 37.59 | 788K | 780K | SEC |
| 2026-02-23 | 02-25 | Horton Amy | VP, Chief Accounting Officer | S 公開市場賣出 | 1.7K | 37.59 | 65K | 128K | SEC |
| 2026-02-23 | 02-25 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 2.4K | 37.59 | 91K | 43.2K | SEC |
| 2026-02-23 | 02-25 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 3.1K | 37.59 | 116K | 154K | SEC |
| 2026-02-23 | 02-25 | Berry Lance A | EVP, COO, CFO & Treasurer | S 公開市場賣出 | 5.0K | 37.59 | 187K | 148K | SEC |
| 2025-12-31 | 01-28 | Stanton Marshall S. | SVP, Clinical & MD Affair | A 獲配股票 | 316 | 26.14 | 8K | 45.6K | SEC |
| 2025-12-31 | 01-28 | Holloway Jean F | SVP, General Counsel | A 獲配股票 | 228 | 26.14 | 6K | 157K | SEC |
| 2025-12-15 | 12-17 | Davis John E | Chief Commercial Officer | S 公開市場賣出 | 5.0K | 45.11 | 226K | 194K | SEC |
| 2025-12-08 | 12-09 | Horton Amy | VP, Chief Accounting Officer | S 公開市場賣出 | 4.6K | 44.42 | 203K | 130K | SEC |
| 2025-12-03 | 12-04 | Mackin James P | President & CEO | S 公開市場賣出(10b5-1) | 30.9K | 45.46 | 1.4M | 801K | SEC |
| 2025-12-03 | 12-04 | Mackin James P | President & CEO | M 選擇權執行 | 30.9K | 29.62 | 916K | 832K | SEC |
| 2025-12-03 | 12-04 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 5.3K | 45.30 | 239K | 156K | SEC |
| 2025-12-03 | 12-04 | Holloway Jean F | SVP, General Counsel | S 公開市場賣出 | 2.0K | 45.30 | 93K | 161K | SEC |
| 2025-12-02 | 12-03 | Mackin James P | President & CEO | S 公開市場賣出(10b5-1) | 30.9K | 45.56 | 1.4M | 801K | SEC |
| 2025-12-02 | 12-03 | Mackin James P | President & CEO | M 選擇權執行 | 30.9K | 29.62 | 916K | 832K | SEC |
| 2025-12-01 | 12-02 | Horton Amy | VP, Chief Accounting Officer | G 贈與 | 750 | – | – | 135K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | M 選擇權執行 | 27.1K | 11.03 | 299K | 71.8K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 18.7K | 44.91 | 840K | 53.1K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 5.7K | 45.35 | 259K | 44.8K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | M 選擇權執行 | 20.3K | 18.44 | 374K | 65.1K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 8.4K | 45.35 | 380K | 44.8K | SEC |
| 2025-11-21 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 14.6K | 44.92 | 655K | 50.5K | SEC |
| 2025-11-20 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 1.4K | 44.28 | 60K | 44.8K | SEC |
| 2025-11-20 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | M 選擇權執行 | 1.4K | 11.03 | 15K | 46.1K | SEC |
| 2025-11-20 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 2.0K | 44.32 | 90K | 44.8K | SEC |
| 2025-11-20 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | M 選擇權執行 | 2.0K | 18.44 | 37K | 46.8K | SEC |
| 2025-11-20 | 11-24 | Stanton Marshall S. | SVP, Clinical & MD Affair | S 公開市場賣出 | 11.9K | 44.14 | 525K | 44.8K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.7M | 150M | 新進 | 新進 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 3.2M | 71.6M | 新進 | 新進 |
| MORGAN STANLEY | 2.6M | 57.5M | 新進 | 新進 |
| Juniper Investment Company, LLC | 2.0M | 45.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | 45.0M | 新進 | 新進 |
| FMR LLC | 2.0M | 44.1M | 新進 | 新進 |
| STATE STREET CORP | 1.9M | 41.8M | 新進 | 新進 |
| Ophir Asset Management Pty Ltd | 1.8M | 40.4M | 新進 | 新進 |
| PERCEPTIVE ADVISORS LLC | 1.7M | 39.0M | 新進 | 新進 |
| Conestoga Capital Advisors, LLC | 1.6M | 36.5M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3M | 28.3M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 25.0M | 新進 | 新進 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1.0M | 23.0M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 988K | 22.2M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 948K | 21.3M | 新進 | 新進 |
| 城堡 CITADEL ADVISORS LLC | 828K | 18.6M | 新進 | 新進 |
| First Eagle Investment Management, LLC | 693K | 15.6M | 新進 | 新進 |
| YARGER WEALTH STRATEGIES, LLC | 634K | 15.3M | 新進 | 新進 |
| ROYCE & ASSOCIATES LP | 639K | 14.4M | 新進 | 新進 |
| NORTHERN TRUST CORP | 551K | 12.4M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 521K | 11.7M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 476K | 10.7M | 新進 | 新進 |
| FRED ALGER MANAGEMENT, LLC | 463K | 10.4M | 新進 | 新進 |
| UBS Group AG | 454K | 10.2M | 新進 | 新進 |
| Invesco Ltd. | 443K | 10.0M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 206 -33 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 206 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 46.3M · 94.9% |
| 合計季末市值 | 1.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 2.9M |
|---|---|
| 與上期比 | +6.6% |
| 佔流通股數 | 6.00% |
| 日均成交量 | 662K |
| 回補天數 | 4.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 2.9M | +6.6% | 6.00% | 662K | 4.4 |
| 2026-08-14 | 2.7M | +1.5% | 5.63% | 857K | 3.2 |
| 2026-07-31 | 2.7M | +8.3% | 5.55% | 568K | 4.8 |
| 2026-07-15 | 2.5M | +14.6% | 5.12% | 550K | 4.5 |
| 2026-06-30 | 2.2M | +15.4% | 4.47% | 1.1M | 2.0 |
| 2026-06-15 | 1.9M | -1.5% | 3.87% | 810K | 2.3 |
| 2026-05-29 | 1.9M | -1.3% | 3.93% | 679K | 2.8 |
| 2026-05-15 | 1.9M | +1.1% | 3.98% | 1.1M | 1.7 |
| 2026-04-30 | 1.9M | -1.2% | 3.94% | 304K | 6.3 |
| 2026-04-15 | 1.9M | +16.6% | 3.99% | 523K | 3.7 |
| 2026-03-31 | 1.7M | -0.4% | 3.42% | 389K | 4.3 |
| 2026-03-13 | 1.7M | +6.3% | 3.43% | 396K | 4.2 |
| 2026-02-27 | 1.6M | +13.6% | 3.23% | 569K | 2.8 |
| 2026-02-13 | 1.4M | -15.4% | 2.84% | 490K | 2.8 |
| 2026-01-30 | 1.6M | +2.6% | 3.36% | 313K | 5.2 |
| 2026-01-15 | 1.6M | +12.6% | 3.27% | 292K | 5.5 |
| 2025-12-31 | 1.4M | +18.9% | 2.91% | 364K | 3.9 |
| 2025-12-15 | 1.2M | -0.1% | 2.45% | 356K | 3.4 |
| 2025-11-28 | 1.2M | -5.8% | 2.45% | 336K | 3.6 |
| 2025-11-14 | 1.3M | -8.1% | 2.60% | 501K | 2.5 |
| 2025-10-31 | 1.4M | +4.9% | 2.83% | 351K | 3.9 |
| 2025-10-15 | 1.3M | -2.3% | 2.70% | 272K | 4.8 |
| 2025-09-30 | 1.3M | +24.1% | 2.76% | 506K | 2.7 |
| 2025-09-15 | 1.1M | -0.8% | 2.22% | 400K | 2.7 |
| 2025-08-29 | 1.1M | +9.7% | 2.24% | 454K | 2.4 |
| 2025-08-15 | 996K | -17.6% | 2.04% | 759K | 1.3 |